Attention Deficit/Hyperactivity Disorder
Updated: 06/16/2006
Source: lef.org
Attention deficit/hyperactivity disorder (ADHD) is a distressing
diagnosis for any parent to hear. It's well known that children with
ADHD are at a disadvantage in school and that ADHD can have long-term
effects. In addition, a number of powerful pharmaceuticals have been
used to treat the condition.
Fortunately, newer findings in nutrition and wellness, and newer
generations of pharmaceuticals, have been developed that can help
children with ADHD gain control over their lives. The Life Extension
Foundation has conducted an extensive survey of the scientific
literature to uncover the safest and best approaches for families
affected by this increasingly common condition.
ADHD is defined as a persistent lack of attention to tasks
(attention deficit) and/or a lack of ability to control impulses and an
increase in physical activity (hyperactivity) that is not typical of
others at a similar stage of development (National Institutes of Health
2006). ADHD is most prevalent in children and teens, although it can
occur in adults. ADHD occurs in 3 to 6 percent of all children in the
United States, with rates as high as 15 percent in some areas (Kasper
DL et al 2005).
According to the fourth edition of the American Psychiatric
Association's Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV), ADHD is now the most commonly diagnosed behavioral disorder
of childhood. Boys with ADHD outnumber girls 3 to 1. Some children
outgrow ADHD, but 60 percent continue to have symptoms (Biederman J et
al 2000).
ADHD: A Typical Profile
The behavior of children who have ADHD typically is affected in many
settings such as at home and school or when they are with friends. The
most prominent feature of ADHD is a consistent pattern of
developmentally inappropriate levels of attention, concentration,
distractibility, hyperactivity, and impulsivity. It is important to
note that these problems must be inappropriate to a child’s
developmental level to be considered ADHD. One concern among physicians
is rampant overdiagnosis of ADHD, in part because the condition has
been so hard to define.
Children who have attention deficits are unable to remain on-task
for extended periods of time. They may appear forgetful, in part
because their inability to attend to information prevents them from
understanding it in the first place. Such children may also have
cognitive and language delays. Children with hyperactivity may fidget,
have difficulty engaging in quiet activities, be excessively talkative,
and always seem to be on the go. Children who have impulse control
problems may be impatient (for example, they may blurt out an answer
before the question has been finished). They may have difficulty
waiting their turn and are often perceived to be intruding on others.
All of these manifestations can cause difficulties in academic and
social settings (Warner-Rogers J et al 2000).
It is common for children with ADHD to be misdiagnosed as having
learning disorders because they often perform poorly on tests that
require information processing and concentration (Hartman CA et al
2004; Weiler MD et al 2000). There is also evidence that adults with
ADHD are more likely to have a variety of addictive behaviors, among
them alcoholism (Ponce AG et al 2000), smoking (Levin ED et al 2001),
and cocaine use (Bandstra ES et al 2001).
What Causes ADHD?
Although the exact causes of ADHD are unknown, it is most likely
caused by an interaction of genetic, environmental, and nutritional
factors, with a strong focus on the interaction of multiple genes
(genetic loading) that together cause ADHD.
There is some evidence that people with ADHD do not produce adequate
quantities of certain neurotransmitters, among them dopamine,
norepinephrine, and serotonin. Some experts theorize that such
deficiencies lead to self-stimulatory behaviors that can increase brain
levels of these chemicals (Comings DE et al 2000; Mitsis EM et al 2000;
Sunohara GA et al 2000).
There may also be some structural and functional abnormalities in
the brain itself in children who have ADHD (Pliszka SR 2002;
Mercugliano M 1999). Evidence suggests that there may be fewer
connections between nerve cells. This would further impair neural
communication already impeded by decreased neurotransmitter levels
(Barkley R 1997). Evidence from functional studies in patients with
ADHD demonstrates decreased blood flow to those areas of the brain in
which “executive function,” including impulse control, is based (Paule
MG et al 2000). There may also be a deficit in the amount of myelin
(insulating material) produced by brain cells in children with ADHD
(Overmeyer S et al 2001).
Diagnosing ADHD
Establishing a diagnosis of ADHD is a considerable challenge,
largely because of the lack of reliable and specific testing and firm
criteria. ADHD has become a high-profile condition (which may result in
it being both overdiagnosed and under diagnosed), depending on
pressures from parents, teachers, and others. Although DSM-IV contains
diagnostic criteria, they are often not followed by health
professionals. Because of the lifelong implications of a diagnosis of
ADHD, most experts recommend a multidisciplinary team approach to both
diagnosis and treatment. Such an approach should involve physicians,
child behavior experts, and parents. Nutritional experts may also be
valuable members of the treatment team.
The core symptoms of ADHD in children are listed below. This list
was adapted from the Centers for Disease Control. It is important to
note that the diagnosis of ADHD cannot be made unless the patient has
experienced these symptoms in ways that are disabling for a 6-month
period. The DSM-IV diagnosis includes:
I. Either A or B:
A. Six or more of the following symptoms of inattention have been
present for at least 6 months to a point that is disruptive and
inappropriate for developmental level:
- Often does not give close attention to details or makes careless mistakes in schoolwork, work, or other activities.
- Often has trouble keeping attention on tasks or play activities.
- Often does not seem to listen when spoken to directly.
- Often does not follow instructions and fails to finish schoolwork,
chores, or duties in the workplace (not due to oppositional behavior or
failure to understand instructions).
- Often has trouble organizing activities.
- Often avoids, dislikes, or does not want to do things that take a
lot of mental effort for a long period of time (such as schoolwork or
homework).
- Often loses things needed for tasks and activities (such as toys, school assignments, pencils, books, or tools).
- Is often easily distracted.
- Is often forgetful in daily activities.
B. Six or more of the following symptoms of
hyperactivity/impulsivity have been present for at least 6 months to an
extent that is disruptive and inappropriate for developmental level:
Hyperactivity:
- Often fidgets with hands or feet or squirms in seat.
- Often gets up from seat when remaining in seat is expected.
- Often runs about or climbs when and where it is not appropriate (adolescents or adults may feel very restless).
- Often has trouble playing or enjoying leisure activities quietly.
- Is often “on the go” or often acts as if “driven by a motor.”
- Often talks excessively.
Impulsivity
- Often blurts out answers before questions have been finished.
- Often has trouble waiting his/her turn.
- Often interrupts or intrudes on others (such as butts into conversations or games).
II. Some symptoms that cause impairment were present before age 7 years.
III. Some impairment from the symptoms is present in two or more settings (such as at school or work and at home).
IV. There must be clear evidence of significant impairment in social, school, or work functioning.
V. The symptoms do not happen only during the course of a pervasive
developmental disorder, schizophrenia, or other psychotic disorder. The
symptoms are not better explained by another mental disorder (such as a
mood disorder, anxiety disorder, dissociative disorder, or personality
disorder).
Traditional Medical Treatment
In addition to behavioral management, medical treatment of ADHD includes stimulant and nonstimulant medications.
Stimulant drugs. Effective prescription drugs are
primarily the so-called stimulant drugs. These agents are known to
increase brain concentrations of a variety of brain neurotransmitters,
most importantly dopamine, and exert a calming effect on people who
have ADHD. Since dopamine enhances signaling between nerve cells that
are involved in task-specific activities and also decreases “noise,” or
“nonsense signaling,” increased concentrations of dopamine are thought
to help individuals stay focused and on-task.
Despite their limitations, stimulants are still considered
first-line treatment for ADHD. They are effective in 70 to 80 percent
of patients. Stimulants are highly effective at alleviating core ADHD
symptoms (such as inattention, hyperactivity, or impulsivity). Original
stimulant preparations had very short periods of action that could
result in dramatic rises and falls in drug levels. Newer long-acting
preparations have been developed to even out these swings.
Even with the newer formulations, some adverse effects are
inevitable. Long-term effects, although unusual, can occur. There is
some evidence, for example, that long-term use of stimulants,
especially methylphenidate (Ritalin®), can cause a delay in growth
(Holtkamp K et al 2002). It is understandable that many parents are
hesitant to give their young children this medication.
While they are effective, stimulant drugs are members of the
amphetamine class, which means they can have significant adverse
effects and hold some potential for abuse. Unfortunately,
methylphenidate has gained popularity as a recreational drug,
especially among adolescents and college students. While
methylphenidate paradoxically acts as a calming drug among people
diagnosed with ADHD, it acts as a stimulant among people who do not
have ADHD. Surveys have indicated that more than 90 percent of college
students and adolescents who abuse prescription drugs identified
methylphenidate as their drug of choice (White BP et al 2006).
Nonstimulant drugs. The negative effects of
stimulant drugs have led to an intensive search for better
alternatives. Atomoxetine is the first nonstimulant drug approved by
the US Food and Drug Administration (FDA) for treatment of ADHD and the
only agent approved by the FDA for treatment of ADHD in adults.
Atomoxetine therapy for ADHD controls symptoms and maintains
remission, and has comparable efficacy with methylphenidate, a
favorable safety profile, and noncontrolled substance status (Christman
AK et al 2004). Atomoxetine is safe and well tolerated (Kelsey DK et al
2004). It effectively reduces ADHD symptoms and improves social
functioning in school-aged children, adolescents, and adults. As with
stimulant medications, atomoxetine should be used with caution in
patients who have hypertension or a cardiovascular disorder (Christman
AK et al 2004).
In addition to atomoxetine, other drugs that increase brain
concentrations of dopamine and/or serotonin have been used with varying
degrees of success. Among these are the anticonvulsant gabapentin
(Hamrin V et al 2001), the dopamine-enhancing antidepressant bupropion
(Daviss WB et al 2001), the wakefulness-promoting drug modafinil
(Taylor FB et al 2000), and donepezil, an acetylcholinesterase
inhibitor that increases brain levels of acetylcholine. Studies,
however, have cast doubt on donepezil's effectiveness (Wilens TE et al
2005).
Nutritional Therapy
As previously mentioned, ADHD is most likely caused by multiple
factors, including nutritional issues. Children with ADHD may have
specific nutrient deficiencies that aggravate their condition. As
researchers learn more about the intersection between diet and
behavioral disorders, the case for nutritional intervention among
children with ADHD becomes more compelling. In the future, it is almost
certain that this multifactorial disease will be treated on multiple
fronts, including with nutritional intervention (Harding KL et al
2003). Already, many progressive parents and physicians are turning to
comprehensive health care options to battle this frustrating condition.
Essential fatty acids. A growing body of scientific
literature is helping parents and doctors better understand the link
between fatty acids and behavioral disorders such as ADHD. The ratio
between omega-3 and omega-6 fatty acids (such as arachidonic acid)
seems especially important. Eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) are omega-3 fatty acids found in flaxseed
oil and cold water fish. In the typical Western diet, we tend to
consume more omega-6 fatty acids relative to omega-3 fatty acids. The
ratio of omega-3 to omega-6 fatty acids has been shown to influence the
development of neurotransmitters and other chemicals that are essential
for normal brain function. Increased intake of omega-3 fatty acids has
been shown to reduce the tendency toward hyperactivity among children
with ADHD (Haag M 2003).
Several studies have examined the role of essential fatty acids in ADHD, with very encouraging results:
- In one pilot study, children with ADHD were given flaxseed oil,
which is rich in alpha-linolenic acid. In the body, alpha-linolenic
acid is metabolized into EPA and DHA. At the end of the study,
researchers found that the symptoms of children with ADHD who were
given the flaxseed oil improved on all measures (Joshi K et al 2006).
- Another study examined the effects of flaxseed oil and fish oil,
which provide varying degrees of omega-3 fatty acids, on adults with
ADHD. The patients were given supplements for 12 weeks. Their blood
levels of omega-3 fatty acids were tracked throughout the 12 weeks.
Researchers found that high-dose fish oil increased omega-3 acids in
the blood relative to omega-6 acids. An imbalance between arachidonic
acid and omega-3 fatty acids is considered a risk factor for ADHD
(Young GS et al 2005).
- Finally, one study compared 20 children with ADHD who were given a
dietary supplement (that included omega-3 fatty acids) to children with
ADHD who were given methylphenidate. The dietary supplement was a mix
of vitamins, minerals, essential fatty acids, probiotics, amino acids,
and phytonutrients. Amazingly, the groups showed almost identical
improvement on commonly accepted measures of ADHD (Harding KL et al
2003).
One study has also indicated that children with ADHD benefit from
intake of a combination of essential fatty acids and vitamin E (Stevens
L et al 2003).
Magnesium and vitamin B6. Combining magnesium and
vitamin B6 has shown promise for reducing symptoms of ADHD. Vitamin B6
has many functions in the body, including assisting in the synthesis of
neurotransmitters and forming myelin, which protect nerves. Magnesium
is also very important; it is involved in more than 300 metabolic
reactions. At least three studies have demonstrated that the
combination of magnesium and vitamin B6 improved behavior, decreased
anxiety and aggression, and improved mobility among children with ADHD
(Nogovitsina OR et al 2006a,b; Nogovitsina OR et al 2005; Mousain-Bosc
M et al 2004).
Iron. Iron deficiency may be implicated in ADHD
(Konofal E et al 2004), although supplementation studies have shown
minimal or no effects (Millichap JG et al 2006). Because of the
potential toxicity of iron supplements, parents should consult their
children’s pediatrician before beginning supplementation.
Zinc. Zinc is a cofactor for production of
neurotransmitters, fatty acids, prostaglandins, and melatonin, and it
indirectly affects metabolism of dopamine and fatty acids. However, the
role of zinc in ADHD is still emerging. Numerous studies have shown
that children with ADHD are often deficient in zinc. However,
researchers have not determined that a zinc deficiency causes ADHD or
that treatment with zinc can improve symptoms of ADHD (Arnold LE et al
2005a,b). Two Turkish studies, however, have tested zinc therapy among
children with ADHD with positive results. In these studies, children
were randomized to groups that received either zinc or placebo. In one
study, the conditions of children who took zinc for 6 weeks improved
(Akhondzadeh S et al 2004). In the second study, zinc as the sole
therapy resulted in significant improvements compared to placebo
(Bilici M et al 2004).
Acetyl-L-carnitine. This superior form of
L-carnitine, which is responsible for transporting fatty acids into the
mitochondria, has been associated with a host of positive health
benefits, including reducing impulsivity. In an animal model of ADHD,
acetyl-L-carnitine was shown to reduce the impulsivity index (Adriani W
et al 2004).
Additional Nutrients and Hormones
Melatonin. Melatonin is a hormone secreted at night
by the pineal gland. It participates in multiple body processes,
including regulation of the sleep/wake cycle. Because many children and
adults who have ADHD also have sleep problems, melatonin can be an
important part of an integrative therapy. By some estimates, up to 25
percent of children with ADHD also have sleep disorders. Unfortunately,
however, conventional therapy treats the hyperactivity portion of the
disease but neglects the sleep disorder (Betancourt-Fursow de Jimenez
YM et al 2006). In one study of 27 children with ADHD and insomnia, 5
milligrams (mg) of melatonin, combined with sleep therapy, helped
reduce insomnia (Weiss MD et al 2006).
Dehydroepiandrosterone (DHEA). DHEA is an important
neuroactive steroid hormone that may be involved in ADHD, although
researchers are still trying to understand the relationship. ADHD is
associated with low blood levels of DHEA, its principal precursor
pregnenolone, and its principal metabolite
dehydroepiandrosterone-sulfate (DHEA-S). Higher blood levels of these
neurosteroids are associated with fewer symptoms (Strous RD et al
2001). Furthermore, a study of adolescent boys with ADHD showed that
DHEA levels rise after a 3-month course of methylphenidate treatment,
which implies that DHEA somehow plays a role in the drug's
effectiveness (Maayan R et al 2003).
Ginkgo biloba and ginseng. A combination of these
two herbs has been studied for its ability to improve symptoms among
patients with ADHD. In a study of 36 children ranging in age from 3 to
17 years old, a combination of Ginkgo biloba and American ginseng was
administered twice a day on an empty stomach for 4 weeks. At the end of
the study, more than 70 percent of patients had experienced improvement
on a widely used measure of ADHD symptoms (Lyon MR et al 2001).